Total Funding
61
32
Total FundingPost-IPO Debt raised
Growth Score
-13 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
175691
Eagle Pharmaceuticals is a company focused on developing and commercializing injectable products in the critical care and oncology areas.
- Debra M. Hussain: SVP, Head of Commercial
David Pernock: President/Chief Commercial OfficerPast Role: Fibrocell Science, Chairman and Chief Executive Officer
About the Company
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.
